Medtronic's SelecrSecure pacing lead:
This article was originally published in Clinica
Medtronic has received US approval to sell what it claims is the industry's first cardiac pacing lead designed to enable physicians to reach selected sites of the right side of the heart. The SelectSecure model 3830 lead is the world's thinnest bipolar lead, said the company, which has now introduced the product in the US. The product is unique in that it comprises a "lumenless design" that allows for flexibility and a smaller body size (4.1F), without sacrificing insulation thickness, the firm explained. A deflectable catheter is used to position the lead in the best locations of the right atrium or ventricle. The lead can be used with pacemakers, implantable cardioverter-defibrillators and cardiac resynchronisation therapy (CRT) devices.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.